# FDA Inspection 1010074 - Phase 4 Pharmaceutical Llc - May 02, 2017

Source: https://www.keypedia.com/records/fda_inspections/phase-4-pharmaceutical-llc/1ece646d-fa4c-4437-bdeb-da55af80fe1d
Source feed: FDA_Inspections

> FDA Inspection 1010074 for Phase 4 Pharmaceutical Llc on May 02, 2017. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010074
- Company Name: Phase 4 Pharmaceutical Llc
- Inspection Date: 2017-05-02
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1010074 - 2017-05-02](https://www.keypedia.com/records/fda_inspections/phase-4-pharmaceutical-llc/d3ef30be-739a-4d9b-bb71-06523085f673)
- [FDA Inspection 950733 - 2015-12-15](https://www.keypedia.com/records/fda_inspections/phase-4-pharmaceutical-llc/310c60ad-77e1-4dda-bd05-3b55897f8de5)
- [FDA Inspection 950733 - 2015-12-15](https://www.keypedia.com/records/fda_inspections/phase-4-pharmaceutical-llc/b6752dd0-68fd-4e69-8bae-5144896f2108)

Company: https://www.keypedia.com/companies/phase-4-pharmaceutical-llc/c38543ce-01d5-494d-8d37-5ec2658ce067

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c